ProBioGen, Immunogenesis in cell line development agreement
Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.
Archives for March 24, 2020
Lonza launches insect medium enabling increased AAV production
Designed specifically for AAVs production to support gene therapies, a medium launched by Lonza is expected to accelerate cell growth while saving developers time and costs.
Insulin designated biologic in ‘landmark moment’
Manufacturers can now apply to the US FDA for the approval of biosimilars to insulin products.